Anti-Human IL17A Therapeutic Antibody (Secukinumab)

Recombinant monoclonal antibody to IL17A. Secukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, and psoriasis. It targets member A from the cytokine family of interleukin 17.
Supplier Creative Biolabs
Product # TAB-069
Pricing Inquiry
Host Human
Target IL17A
Species Reactivity Human
Type IgG1 - kappa
Applications IF, IHC, ELISA, FC
Storage At -20°C for one year.
Feedback